10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
The integration of artificial intelligence (AI) and big data in infectious disease management is transforming the way public health officials and clinicians tackle the global burden of infections. With the power of Artificial Intelligence and Big Data in Infectious Disease Management, AI-driven predictive models can process complex datasets, helping to anticipate outbreaks and track disease progression. Big data analytics provides insights into transmission patterns, resistance trends, and patient demographics, enabling more effective surveillance and intervention strategies. In managing infectious diseases, AI applications are also instrumental in drug discovery, diagnostics, and optimizing treatment regimens. With continuous advancements in AI technology and the expanding availability of big data, the future of infectious disease management holds immense potential for improving global health outcomes.
By signing up, you agree to join our mailing list to receive information and updates.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Host brakes on viral inflammation
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : The impact of expanded adolescent vaccination against Omicron waves depends on the epidemic status: A mathematical modelling study
Anna Fairweather, University of Oxford, United Kingdom
Title : Comprehensive HIV care through integrated STI and primary care services at the LGBTQ+ Center of Southern Nevada
Darya V Fridman, The Southern Nevada LGBTQ+ Center, United States
Title : Meeting the needs of adults aged 50+ with HIV through the new opening of a primary care clinic at the LGBTQ Center of Southern Nevada
Darya V Fridman, The Southern Nevada LGBTQ+ Center, United States
Title : Camostat-polysaccharide dual-action nasal spray for mucosal barrier-driven prevention of viral infections
Yujeong Na, Daewoong Pharmaceutical Co., Ltd, Korea, Democratic People's Republic of